(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -99.14%-2.17M | -1.09M |
Payments to suppliers for goods and services | -0.43%-1.09M | ---1.09M |
Other cash payments from operating activities | ---1.08M | ---- |
Direct interest received | 9.78%40.59K | --36.98K |
Operating cash flow | -102.27%-2.13M | ---1.05M |
Investing cash flow | ||
Cash flow from continuing investing activities | -14.86%-2.22M | -1.94M |
Capital expenditure reported | -20.09%-2.21M | ---1.84M |
Net PPE purchase and sale | 87.53%-11.74K | ---94.17K |
Cash from discontinued investing activities | ||
Investing cash flow | -14.86%-2.22M | ---1.94M |
Financing cash flow | ||
Cash flow from continuing financing activities | 1,295.04%3.86M | -322.75K |
Net common stock issuance | 1,295.04%3.86M | ---322.75K |
Cash from discontinued financing activities | ||
Financing cash flow | 1,295.04%3.86M | ---322.75K |
Net cash flow | ||
Beginning cash position | -55.07%2.71M | --6.02M |
Current changes in cash | 85.04%-495.21K | ---3.31M |
Effect of exchange rate changes | -1,116.07%-61.66K | ---5.07K |
End cash Position | -20.58%2.15M | --2.71M |
Free cash from | -45.65%-4.35M | ---2.99M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data